论文部分内容阅读
免疫核糖核酸是一种富有核酸的制剂。它是在体外与特异性抗原接触后,或在体内经特异性抗原致敏的淋巴样细胞和组织的提出物。已证实,免疫核糖核酸可以诱使正常、无免疫性的淋巴样细胞参与体外和体内特异性细胞和体液的免疫反应。既往的研究已经表明,免疫核糖核酸制剂是从与肿瘤细胞接种后的动物淋巴样器官内提出的。这种制剂可在动物模型和人体肿瘤系内传递伴有抗原的抗肿瘤特异性免疫反应。
Immune RNA is a nucleic acid rich preparation. It is a proposition of lymphoid cells and tissues that are sensitized to specific antigens either in vitro or in contact with specific antigens. It has been demonstrated that immunological ribonucleic acid can induce normal, non-immune lymphoid cells to participate in the immune responses of specific cellular and humoral cells in vitro and in vivo. Previous studies have shown that immunological ribonucleic acid preparations are presented within the lymphoid organs of animals after inoculation with tumor cells. This formulation delivers anti-tumor specific immune responses with antigens in animal models and human tumor lines.